Melanocyte stem cells (McSCs) and mouse models of hair graying serve as useful systems to uncover mechanisms involved in stem cell self-renewal and the maintenance of regenerating tissues. Interested in assessing genetic variants that influence McSC maintenance, we found previously that heterozygosity for the melanogenesis associated transcription factor, Mitf, exacerbates McSC differentiation and hair graying in mice that are predisposed for this phenotype. Based on transcriptome and molecular analyses of Mitf mi-vga9/+ mice, we report a novel role for MITF in the regulation of systemic innate immune gene expression. We also demonstrate that the viral mimic poly(I:C) is sufficient to expose genetic susceptibility to hair graying. These observations point to a critical suppressor of innate immunity, the consequences of innate immune dysregulation on pigmentation, both of which may have implications in the autoimmune, depigmenting disease, vitiligo.
Author summary
Hair pigmentation over the course of a lifetime depends on melanocyte stem cells that reside in the hair follicle. As old hairs fall out and new hairs grow in, melanocyte stem cells serve as a reservoir for the melanocytes that produce the pigment that gives hair its visible color. The loss of these stem cells leads to the growth of nonpigmented, or gray, hairs. Evaluating mouse models of hair graying can reveal key aspects of melanocyte stem cell biology. Using this approach, we discovered a novel role for the melanogenesis
Introduction
In the 1980s, a handful of studies reported that exposure to murine leukemia virus (MuLV), either at mid-gestation or perinatally, is sufficient to drive premature hair graying in mice [1] [2] [3] . Early infection with MuLV does not lead to immediate loss of hair pigmentation and instead produces an adult-onset, progressive hypopigmentation phenotype, suggestive of a failure in melanocyte lineage regeneration. These observations suggest a role for innate immune activation in adult hypopigmentation disorders, but how this phenomenon is mediated within the postnatal melanocyte lineage remains unresolved. Using approaches to look for genetic modifiers of hair graying in mice and transcriptomic analysis of melanocyte stem cells (McSCs), we identify an exciting and unexpected link between the melanogenesis associated transcription factor, MITF, and the suppression of a type I interferon (IFN) gene signature. This discovery creates a unique opportunity to investigate how innate immune gene expression is regulated in postnatal melanocytes and how its dysregulation affects McSCs and the regeneration of postnatal pigmentation during hair cycling.
During hair growth, McSCs produce the melanocyte progeny that differentiate and deposit melanin into the hair shaft. Mouse models reveal that hair graying, both acute and age related, is frequently preceded by a failure in McSC maintenance or dysregulated generation of melanocyte progeny. Both lead to the production of nonpigmented, or gray, hair shafts. Hair graying can be elicited through a number of mechanisms-disrupting the signaling pathways associated with the Kit receptor, Notch receptor, Endothelin receptor type B, Raf kinase, Transforming growth factor beta, or Wnt [4] [5] [6] [7] [8] [9] [10] [11] ; loss of anti-apoptotic control [12, 13] ; melanocyte-specific dysregulation of chromatin remodeling complexes [14] ; exposure to genotoxic stress [15, 16] ; changes in sex determining region Y-box 10 (SOX10) or MITF-mediated transcriptional regulation [13, 17] ; vitiligo-like T-cell-mediated destruction of melanocytes [18] ; and aging itself [13] .
In particular, MITF, the gene encoding the micropthalmia-associated transcription factor, is essential at multiple stages of the melanocyte life cycle. Across species, MITF is required for the specification and survival of the melanocyte precursors, or melanoblasts, during early neural crest migration [19] [20] [21] . Loss of Mitf expression results in the near-complete depletion of embryonic melanoblasts, and this leads to mice born with a fully white coat [22] . During melanogenesis, MITF transcriptionally regulates a number of pigmentation genes involved in the biosynthesis of melanin and the trafficking of melanosomes. Regulation of MITF activity levels also influences the dynamic transition between the states of melanocyte migration, proliferation, and differentiation [23] [24] [25] .
Our interest in the role of MITF in hair graying was spurred by our previous observation that a genetic interaction exists between Mitf and the Sox10 transgene, Tg(Dct-Sox10) [17] . Tg (DctSox10) mice conditionally overexpress Sox10 within the melanocyte lineage, and this leads to the premature differentiation of McSCs, eventual McSC depletion, and progressive hair graying. Because SOX10 transcriptionally activates the Mitf gene and the MITF protein promotes melanocyte differentiation, we anticipated that reducing Mitf expression might alleviate Tg(DctSox10)-mediated hair graying. We tested this using the Mitf-null allele, Mitf mi-vga9 , which in the heterozygous state does not lead to apparent McSC dysfunction or hair graying. However, in contrast to our expectations, Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice exhibit sparsely distributed yet noticeable nonpigmented or "gray" hairs throughout their coat prior to their Tg(Dct-Sox10)/0 littermates (Fig 1A) . Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice also show increased differentiation of McSCs, as indicated by excessive ectopic pigmentation within the stem cell niche (hair bulge) of their hair follicles. Intensified adult-onset hair graying associated with Mitf mi-vga9 is particularly evident when the Tg(Dct-Sox10) transgene is homozygous and animals are imaged over time (Fig 1B) . We interpreted this outcome as contrary to the canonical role of MITF, in which high levels of MITF activity, rather than low, are associated with cell cycle arrest and melanocyte differentiation [26] . This interpretation is reinforced further by the fact that McSCs in Mitf vit/vit mice, which carry a hypomorphic mutation of Mitf, also exhibit premature McSC differentiation and hair graying even in the absence of Tg(DctSox10) [13] . This suggests a novel contribution of MITF to the regulation of McSC maintenance and melanocyte lineage regeneration postnatally.
With this in mind, we performed genomic analysis of wild-type and Mitf mi-vga9/+ McSCs and discovered that haploinsufficiency for Mitf results in a marked and chronic up-regulation of a type I IFN gene signature in this stem cell population. To better understand the contribution of innate immune suppression in postnatal melanogenesis, we further validated this immune signature in the skin and melanoblasts (the melanocyte precursors) of Mitf mi-vga9/+ mice. We evaluate the possibility that MITF acts as negative transcriptional regulator of innate immune target genes, and we assess the consequence of innate immune pathway activation on the regeneration of the melanocyte lineage during hair cycling.
Results

Mitf haploinsufficiency is associated with an up-regulation of a type I IFNregulated gene expression signature in McSCs and melanoblasts
In order to assess the effects of Mitf mi-vga9/+ on gene expression in vivo, McSCs were isolated from the dermis of adult mice at 8 weeks of age. At this time point, hairs across the body of the mouse are synchronized in the hair stage of telogen [27] . During telogen, the hair follicle does not have a hair bulb or differentiated melanocytes, and McSCs are the only melanocytic cells present within the hair. They can be identified by their expression of the melanogenic enzyme dopachrome tautomerase (DCT) and the transmembrane receptor KIT, and they are observed in the hair bulge (the upper region of the telogen-stage hair that lies at the insertion point of the arrector pili muscle) and secondary hair germ (the lower region of the telogen-stage hair nearest the dermal papilla; Fig 2A) . In order to isolate these McSCs from telogen hairs, the dermis of Mitf mi-vga9/+ and wild-type mice was dissociated and immunolabeled with two cell-surface markers, KIT and cluster of differentiation 45 (CD45). Fluorescence-activated cell sorting (FACS) was then used to distinguish McSCs (KIT+/CD45−) from mast cells (KIT+/CD45+; Fig 2B) . When assessed in vitro 1, 3, or 5 days after sorting, greater than 92% of the KIT+/ CD45− population of cells express the melanocytic protein DCT and begin to produce pigment at 5 days (Fig 2C and 2D) . Additionally, because MITF is a known transcriptional regulator of the Kit gene [20, 28] (Fig 2E) . This suggests that this sorting strategy is adequate to produce a highly enriched pool of McSCs for transcriptomic analysis. RNA isolated from the KIT+/CD45− McSC populations obtained from the dermis of wild-type and Mitf mi-vga9/+ mice was then subjected to RNA sequencing (RNA-seq). . (A) Dorsal images of two female littermates taken at P110. At this age, the coat of Tg(Dct-Sox10)/0 mice appears solid black, while the coat of Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice exhibits a small number of gray hairs along its back. Brightfield images of histological sections of the skins from these mice reveal increased ectopic pigmentation (arrows) within the hair bulge (region between the dotted lines) of hairs from Tg(Dct-Sox10)/0; Mitf mi-vga9/+ animals in comparison to Tg(Dct-Sox10)/0 animals. (B) Dorsal images of two female littermates taken at P37 and P110. At P37, Tg(Dct-Sox10)/Tg(Dct-Sox10) mice exhibit a black coat with congenital white spotting on the belly and back. These mice experience progressive hair graying and by P110 exhibit a "salt and pepper" coat color in regions of the back fur that were originally black. In comparison to Tg(DctSox10)/Tg(Dct-Sox10) mice, hair graying in Tg(Dct-Sox10)/Tg(Dct-Sox10); Mitf mi-vga9/+ mice at P110 is more severe, with a majority of the back fur exhibiting gray hairs. The images for this figure were generated in the original study presented in [17] . McSC, melanocyte stem cell; P, postnatal day; SG, sebaceous gland. . Up-regulation of this particular subset of genes is known as the "IFN signature" and is often associated with viral infection and autoimmune disorders [32] . To rule out the possibility that this ISG signature was due to a microbial infection of our Mitf mi-vga9 line at the time that
McSCs were harvested for FACS, we assessed ISG expression by quantitative reverse [37] .
Techniques for expanding McSCs in culture for in vitro analysis are not well established, so we instead evaluated primary melanoblasts for their response to viral mimic. Primary melanoblasts refer to the highly proliferative, KIT+, melanocyte precursors that invade the developing hair follicle and give rise to either McSCs or differentiated melanocytes during perinatal hair morphogenesis (Fig 3B) . Using the same FACS strategy as presented above (Fig 2B) , KIT+/CD45− primary melanoblasts can be isolated from the whole skin of pups on P1. 5 
MITF binds the promotor of several ISGs and transcriptionally represses ISG expression in vitro
MITF is a transcription factor that promotes the direct and indirect regulation of a number of genes essential for melanocyte development, differentiation, proliferation, and survival [38] . Thus, we investigated whether the IFN signature observed in Mitf mi-vga9/+ McSCs and melanoblasts may be dependent on MITF's role as a transcription factor. To determine whether reduction of Mitf is sufficient to lead to a direct change in ISG expression autonomous to the melanocyte, we knocked down Mitf in the immortalized mouse melanocyte cell line melan-a using a small interfering RNA (siRNA) approach. Intracellular delivery of siRNAs can elicit a nonspecific innate immune response that can be mitigated by incorporating 2 0 -O-methyl-uridine or guanosine nucleosides into at least one strand of the siRNA duplex [39] . Thus, we generated two siRNAs-a standard siRNA against Mitf (siMitf [40] ) and a modified Mitf siRNA with an identical sequence but synthesized to include three 2 0 -O-methyl groups along each strand of siRNA (siMitf-OM). In line with MITF repression of ISG expression, knockdown of Mitf with either siMitf or siMitf-OM leads to robust up-regulation of the ISGs Ifih1, Ifit3, Irf7, Isg15, and Stat1 within 48 hours of transfection in comparison to a scrambled siRNA control (siMitf-scram; Fig 4A) . These data support the premise that the IFN signature observed in Mitf mi-vga9/+ mice may be due to MITF-mediated gene regulation of ISGs.
Among the genes differentially expressed in Mitf mi-vga9/+ McSCs, we were particularly interested in IFN regulatory factor 4, Irf4. In human melanocytes, MITF binds and activates Irf4 via an intronic enhancer [42] , and in turn, IRF4 can transcriptionally regulate IFN signaling by repressing the master regulatory factor for IFN gene expression, Irf7 [43, 44] . A genome-wide association study of Latin Americans also identified Irf4 as a locus associated with hair graying [45] . Because Irf4 and Irf7 exhibit a reciprocal relationship in
and Irf7 is up; S2 Data), we asked whether Irf4 may be indirectly responsible for the up-regulation of ISGs in Mitf mi-vga9/+ melanocytes. However, within the 48-hour time frame that is sufficient for Mitf knockdown to result in ISG up-regulation, we did not observe consistent downregulation of Irf4 between the two Mitf siRNAs (Fig 4A) . As a control, we further confirmed that cells being treated with either siMitf or siMitf-OM results in the predictable down-regulation of the melanosomal gene Pmel17, which MITF is known to transcriptionally activate ( Fig  4A ; [46] ). Based on these observations, we anticipated that the up-regulation of ISGs observed with Mitf knockdown cannot be IRF4 dependent. Indeed, using two unique Irf4 siRNAs (siIrf4_a and siIrf4_b), Irf4 gene expression can be significantly reduced in comparison to a negative control siRNA (siNC1). However, when considering the results of both Irf4 siRNAs, Irf4 knockdown does not lead to the consistent up-regulation or Irf7 or any of the other ISGs analyzed (Fig 4B) . Altogether, these results support a novel role for MITF in suppressing the basal IFN signature in melanocytes in vitro and indicate that MITF does not mediate this response through Irf4.
An alternate mechanism by which MITF may participate in regulation of innate immune genes is through a direct interaction with their cis-regulatory regions, as is the case with many pigmentation genes [46] [47] [48] [49] . To investigate this, we screened a previously published MITF chromation immunoprecipitation sequencing (ChIP-seq) dataset for binding of MITF to regulatory regions of innate immune genes [41] . The genomic coordinates of the MITF ChIP-seq peaks found in human primary melanocytes and COLO829 melanoma cells, reported in Webster et al. 2014 [41] , were converted from genome build GRCh37/hg19 to NCBI37/mm9 (Galaxy Liftover), and putative target genes were identified using GREAT, version 3.0.0 [50] . For the set of genes that exhibit MITF ChIP-seq peaks within 5 kb of their transcription start site in either direction (6,771), we found 108 genes that are also differentially expressed by greater than 1.5-fold in Mitf mi-vga9/+ McSCs (Fig 4C, S4 Data) . This overlap is under enriched by but also reveals a number of innate immune genes that may also be under MITF transcriptional control (Fig 4C) . Of the nine innate immune DEGs, seven exhibit an MITF ChIP-seq peak that spans their transcription start site and is congruent with a role for MITF in the direct . A centromeric DNA sequence was amplified as a negative control (neg con). Error bars indicate mean ± standard deviation of two independent ChIP pulldowns. The raw data used to generate the graphs in (A), (B), and (D) are available in S1 Data. Actb, actin beta; ChIP, chromatin immunoprecipitation; ChIP-qPCR, chromatin immunoprecipitation quantitative polymerase chain reaction; ChIP-seq, chromatin immunoprecipitation sequencing; DEG, differentially expressed gene; IgG, immunoglobulin G; McSC, melanocyte stem cell; MITF, melanogenesis associated transcription factor; neg con, negative control; siNC1, nontargeting control siRNA; siRNA, small interfering RNA. regulation of these genes at their promotor ( Table 1) . In order to confirm that MITF binds to these loci in mouse melanocytes, we assessed MITF occupancy using chromatin immunoprecipitation quantitative polymerase chain reaction (ChIP-qPCR) for three of the seven ISGs in melan-a cells. Significant chromatin immunoprecipitation (ChIP) enrichment of MITF was observed at the promoter regions of all three of the ISGs predicted to be MITF targets (Ifih1, Ifit3, and Stat1) as well as at the promoter region of a known MITF target gene, Dct (Fig 4D) . No MITF enrichment was observed for the negative control region, a sequence within the centromere. These observations support a direct regulatory role for MITF in the repression of at least some ISGs within melanocytes. An IFN signature is commonly detected in affected tissues of patients afflicted with autoimmune disease. Using the same mice as in Fig 5A, animals. Moreover, immunolabeling for CD3ε, CD4, CD8, and CD11b indicates no overt change in the density of these immune cell populations (Fig 5B, S2 Fig) . Thus, the increased hair graying associated with Mitf mi-vga9/+ is likely not the result of immune cell-mediated destruction of melanocytes.
Tg(Dct
Reduction of Ifih1 is not sufficient to rescue Mitf mi-vga9
-mediated hair graying Recent genome-wide association studies have led to the identification of function-reducing mutations in interferon induced with helicase C domain 1 (Ifih1) as protective against vitiligo in humans [53] . Ifih1 is one of the direct transcriptional targets of MITF identified above (Fig  4) and encodes for the protein MDA5. MDA5 sits at the top of the type I innate immune signaling cascade and functions as a cytoplasmic PRR that responds to pathogen-associated molecular patterns (PAMPs) like viral RNA [54] . Gain-of-function mutations of Ifih1 in humans or overexpression of Ifih1 in mice is associated with a sustained IFN gene signature and makes it a reasonable candidate for mediating a similar effect downstream of Mitf mi-vga9/+ [55, 56] . Thus, we were interested to evaluate whether Ifih1 haploinsufficiency would be sufficient to reduce the hair graying caused by Mitf mi-vga9 in the context of Tg(Dct-Sox10).
Hair graying associated with Tg(Dct-Sox10) is most readily visible in mice that are homozygous for the transgene, with Tg(Dct-Sox10)/Tg(Dct-Sox10); Mitf mi-vga9/+ animals exhibiting robust graying at 110 days (Fig 1) . ) does not reverse hair graying to the levels observed in Tg(Dct-Sox10)/Tg(Dct-Sox10) mice (Fig 6,  S3 Fig) . . This may indicate that the influence of MITF in innate immune regulation extends beyond the regulation of an individual gene, which is consistent with the fact that Ifih1 is not the only innate immune target gene directly downstream of MITF (as shown in Fig 4) .
Systemic poly(I:C) administration exacerbates hair graying in genetically susceptible mice
Up to this point, it is still unclear whether the innate immune dysregulation associated with Mitf mi-vga9 contributes to elevated hair graying in Tg(Dct-Sox10) mice or whether these two phenomena are merely correlated. To investigate if the activation of innate immune signaling is sufficient to mediate changes in McSC maintenance and hair graying independent of Mitf, we asked if hair graying can be induced in mice exposed systemically to the viral mimic poly(I: C). Poly(I:C) administered in vivo by intraperitoneal injection induces type I IFN production, which is detectable in the blood serum and lymphoid system [37, 57] . This in turn initiates the antiviral response via up-regulation of ISGs to limit viral replication [58] . To mimic the combination of Mitf mi-vga9 and Tg(DctSox10) that leads to exacerbated hair graying, we examined Poly(I:C)-mediated innate immune activation on the Tg(Dct-Sox10) background and compared it to wild-type.
To assess the effects of poly(I:C) on hair pigmentation, hairs along the lower back of each mouse were plucked to synchronize and activate the hair cycle, and the mice were injected with poly(I:C) for 3 days sequentially, beginning at 4 days post plucking. The presence of nonpigmented, gray hairs is detected by visual inspection once the hairs have emerged from the skin. Notably, treatment with this viral mimic is sufficient to increase the amount of gray hairs present in the plucked area in Tg(Dct-Sox10)/0 mice but not adequate to induce hair graying on the wild-type background (Fig 7A) . By immunolabeling for the melanocyte marker DCT on skin sections from these mice, we demonstrate that this hair graying phenotype is the result of the quantitative reduction of McSCs (DCT+ cells in the hair bulge) and melanocytes (Dct+ cells in the hair bulb; Fig 7B and 7C) . This same cell loss is not observed in wild-type animals that are treated with poly(I:C). Taken together, these results suggest that proper regulation of innate immune signaling during active hair growth is essential to both McSCs and differentiating [17] . However, the proportion of ectopically pigmented McSCs in Tg(Dct-Sox10)/0 mice treated with poly(I:C) is significantly lower than in Tg(Dct-Sox10)/0 mice given the vehicle control (Fig 7D) . We surmise that the drop in overall McSC numbers observed in poly(I:C)-treated Tg(Dct-Sox10)/0 mice (shown in Fig 7B) is due to the specific loss of McSCs that have inappropriately differentiated, and that the loss of the these McSCs either occurred at an earlier time point or via a mechanism that does not involve T-cell infiltration or CC3-associated apoptosis. Interestingly, hair graying in Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice is more progressive than the acute graying observed in Tg(Dct-Sox10)/0 mice treated with poly(I:C) [17] , and hair graying in Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice is preceded by excessive McSC differentiation, a phenotype that we do not observe in the Tg(Dct-Sox10)/0 mice treated with poly(I:C). In the future, it will be important to evaluate whether lower dosages of poly(I:C) can drive McSC differentiation or whether these two hair graying models represent distinct cellular pathologies. ) also exhibit differential expression of ISGs in skin and spleen [60] . MC1R and MITF exist in a positive feedback regulatory loop, in which MC1R activation leads to cAMP/CREBdependent up-regulation of Mitf [61] , and MITF acts as a transcriptional activator of Mc1R gene expression [47, 62] . These observations further highlight a link between key melanocyte proteins and the expression of genes involved in the innate immune response.
Discussion
The involvement of MITF in ISG regulation and hair graying is particularly relevant in light of the increasing number of studies indicating an innate immune component to vitiligo [63] . In humans, association studies identified IFIH1 as well as the innate immune genes, NLR family pyrin domain containing 1 (NLRP1) and toll like receptor adaptor molecule 1 (TICAM1), as susceptibility loci associated with generalized vitiligo [53, [64] [65] [66] . NLRP1 and TICAM1 encode the proteins for a PAMP receptor involved in microbial sensing and an adapter molecule involved in innate immune Toll-like receptor signaling, respectively. Infiltrations of active natural killer cells and inflammatory dendritic cells, both innate immune effector cells, are also observed in the lesional skin of vitiligo patients [67, 68] . In the Smyth line chickens, an avian model of spontaneous vitiligo, global gene expression changes associated with the innate immune pathway are observed during both the onset and progression of vitiliginous disease [69] . Additionally, vaccination of these birds with live turkey herpesvirus greatly increases the incidence of hypopigmentation in this susceptible avian line [70, 71] . Further investigation into the molecular mechanisms that drive the hair graying phenotypes associated with McSC and melanocyte loss in Tg(Dct-Sox10)/0; Mitf mi-vga9/+ mice or Tg(Dct-Sox10)/0 mice treated with poly(I:C) may provide new insight into the role of innate immune regulation in hypopigmentary disease. We do not yet understand why only the Tg(Dct-Sox10) mice are sensitive to poly(I:C). Some have speculated that melanocytes produce byproducts that act as endogenous damageassociated molecular patterns (DAMPs) in response to cellular stress [72] . DAMPs, like PAMPs, have the capacity to initiate PRR activation but do so in the absence of virus in a process known as sterile inflammation. Within Tg(Dct-Sox10) mice, overexpression of Sox10 drives the production of aberrant pigmentation with the McSCs [17] , and we can now use the Tg(Dct-Sox10) line as a model to ask whether this process leads to the triggering of damageassociated innate immune effectors.
Few reports describe loss of hair pigmentation or vitiligo-like symptoms in mammalian model systems or human patients after exposure to virus, viral mimic, or elevated type I IFN. In a set of case reports of IFN-α-induced vitiligo after treatment of hepatitis C, it is postulated that the reason hair graying is infrequently observed in hepatitis C patients is because IFN treatment is "only sufficient to unmask vitiligo in susceptible individuals" [73] . This idea is encouraged by our observations that neither Mitf mi-vga9/+ nor poly(I:C) treatment on its own is sufficient to induce changes in postnatal pigmentation in mice, but both can modify hair graying when combined with the susceptible Tg(Dct-Sox10) background. Other examples demonstrate that even with an elevated basal IFN signature, additional environmental or genetic factors are often required to unmask autoimmune disorders, suggesting that this phenomenon is not limited to melanocyte pathologies. For instance, mice expressing multiple copies of an Ifih1 transgene spontaneously generate type I IFN and exhibit no overt phenotype, but increase disease severity when crossed with a lupus-prone strain [55] . Genetic variations in Ifih1 in humans are also associated with increased type I IFN signaling and an increased risk for the development of a number of autoimmune disorders, including Aicardi-Goutieres syndrome, systemic lupus erythematosus, and type I diabetes [56, 74, 75] . Finally, it is important to mention that while this study has focused on assessing the potential role of MITF in the regulation of ISGs autonomous to the melanocyte, these data do not exclude the possibility that a nonautonomous source of IFN also contributes to the ISG signature observed in the melanoblasts and McSCs isolated from Mitf mi-vga9/+ animals. For instance, in addition to melanocytes, MITF is also indispensable for proper mast cell development.
Beyond their well-known role in the allergic response, mast cells are also recognized as effectors and modulators of the innate immune response [76, 77] . While we did not observe a change in the number of mast cells in Mitf mi-vga9/+ mice (Fig 5B) , other studies have reported that animals that are homozygous for Mitf mi-vga9 show significantly reduced mast cell numbers, defects in mast cell differentiation and proliferation, and a reduced ability to resist bacterial infection [52, 78, 79] . Conditional rescue of Mitf expression within the melanocyte lineage of Mitf mi-vga9/+ mice would help determine whether nonautonomous mechanisms contribute to ISG expression in melanocytic cells and would further refine our understanding of the interplay between melanocyte biology and innate immune signaling. In summary, we describe a negative regulatory role for MITF in the expression of innate immune genes in melanocytes in vitro and establish the Mitf mi-vga9/+ mouse line as one in which the McSCs, melanoblasts, and whole skin exhibit a chronically elevated IFN signature. This finding describes a new mechanism by which melanocytes can intrinsically regulate their innate immune response, the implications of which are relevant to both melanocyte physiology and disease. Our data also highlight poly(I:C)-treated, Tg(Dct-Sox10) mice as one of very few examples of an in vivo, innate immune-related, hair graying mouse model. The fact that genetically distinct mice respond differently to poly(I:C) is noteworthy and may help to explain anecdotal stories in humans of spontaneous hair graying after viral infection.
Materials and methods
Ethics statement
All research completed in the manuscript was performed under the guidance of the UAB IACUC or NIH IACUC and is associated with the following animal protocols: UAB 20382 (to MLH); NCI-Frederick 17-031 (to GM); NHGRI G-94-7 (to WJP).
Animals, mouse crosses, genotyping
Mitf mi-vga9 mice on a mixed C57BL/6 × C3H genetic background were received as a gift (H.
Arnheiter [80] ) and rederived on C57BL/6J. Mitf mi-vga9 mice were maintained by intercross and backcross to C57BL/6J. To generate the Mitf mi-vga9/+ mice for RNA-seq analysis (Fig 3, S2 Data), Mitf mi-vga9 homozygotes were backcrossed to C57BL/6J mice. To generate the wild-type mice for RNA-seq analysis, C57BL/6J mice were intercrossed. The wild-type and Mitf mi-vga9/+ mice used for the qRT-PCR of skin in S1 Fig were generated as part of an unrelated study and are also homozygous for the Dct-rtTA transgene [81] . The Dct-rtTA transgene is used for doxycycline-induced expression of tetracycline responsive elements in the presence of doxycycline. These animals were age-matched control animals and as part of this unrelated experiment were not treated with doxycycline. The +/+; rtTA/rtTA animals were generated by mating +/+; rtTA/rtTA and +/+; rtTA/rtTA animals. The Mitf
mi-vga9/+
; rtTA/rtTA animals were generated by using Mitf mi-vga9/ mi-vga9 ; rtTA/rtTA animals that were also heterozygous for a tetracycline inducible Mitf transgene and mating them with +/+; rtTA/rtTA animals. To generate the Mitf mi-vga9/+ and wild-type animals used for primary melanoblast isolation (Fig 3) , Mitf mi-vga9/+ mice were backcrossed to C57BL/6J mice and the littermates were used for analysis. The Tg(Dct-Sox10) transgenic line was generated on the FVB/N background and maintained through a combination of backcrossing to C57BL/6J and by intercross (Tg(Dct-Sox10) CF1-10Pav [82] ). To generate the double and single mutants used for the analysis of gene expression in skin (Fig 5) , Mitf mi-vga9/+ mice were crossed to Tg(Dct-Sox10)/0 mice and the littermates used for analysis. To generate the Tg(Dct-Sox10)/0 for treatment with poly(I:C) (Fig  7) , Tg(Dct-Sox10) homozygotes were backcrossed to C57BL/6J mice. Ifih tm1.1Cln homozygote mice were obtained from JAX (015812, [37] ) and crossed to Tg (Dct-Sox10)/0 mice. The Tg(Dct-Sox10)/0; Ifih tm1.1Cln/+ progeny from this cross were mated further with Tg(Dct-Sox10)/Tg(Dct-Sox10); Mitf mi-vga9/+ mice to assess Ifih tm1.1Cln rescue (Fig 6) . All mice were genotyped using DNA isolated from tail tips and PCR analysis. Primers and cycling conditions for the Mitf mi-vga9 and Tg(Dct-Sox10) alleles were described previously [17] .
The Ifih tm1.1Cln allele was amplified under standard PCR conditions (30 cycles of 45 seconds at 94˚C, 45 seconds at 65˚C, and 60 seconds at 72˚C), using the genotyping primers described at JAX: Ifih1_common_reverse, CTTCTGTTCTTCCTGGGAGACC; Ifih1_wildtype_forward, GGGACTATTGACAGTCGAAGAC; and Ifih1_mutant_forward, CCCCGGTCAAAGCTG AATAAAT.
FACS isolation of McSCs and melanoblasts
Single cell dermal isolations were generated from P1.5 or 8-week-old mice and sorted by FACS to obtain melanoblasts or McSCs, respectively. Cells of the melanocyte lineage were identified by their surface expression of the receptor KIT. Both melanoblasts and McSCs reside in the hair follicle at these respective time points and exhibit KIT+ immunolabeling (Figs 2  and 3 ). This isolation method was adapted from previously published protocols [83] [84]. In brief, trunk skin was incubated in 0.25% Trypsin-EDTA to separate the dermis from the epidermis. The dermis was further dissociated by enzymatic treatment with 0.3 mg/mL Liberase TL (Roche) and then physically disrupted by passing the dermal cell solution forcefully through a syringe-type, 70 uM Filcon filter (BD Biosciences). Dermal cells were labeled with the cell surface markers, KIT (CD117, BD Pharmingen) and CD45.2 (BD Pharmingen), and assessed for fluorescence on a FACSAria (Becton Dickinson). Cells of the melanocyte lineage were positively selected for by gating on the KIT+, CD45.2− cell population. Mast cells were negatively selected away by removing any double positive cells (KIT+, CD45.2+) (Fig 2) . Analysis of the cell populations within FACS gates was performed using FlowJo software.
RNA isolation and qRT-PCR
Cells and tissues for qRT-PCR analysis were harvested in TRIzol reagent (ThermoFisher) and tissues homogenized using a BeadBlaster (Benchmark 
RNA-seq and differential gene expression analysis
McSCs from approximately ten 8-week-old animals were pooled to generate enough RNA to serve as one biological replicate. RNA quality for RNA-seq was assessed by Bioanalyzer (Agilent), and only samples with RIN scores >7.5 were used. mRNA libraries were constructed from about 200 ng total RNA using the Illumina TruSeq RNA Sample Prep Kits, version 2. The resulting cDNA was fragmented using a Covaris E210. Library amplification was performed using 16 cycles. Unique barcode adapters were applied to each library. Libraries were pooled in equimolar ratio and sequenced together on a HiSeq 2000 with version 3 flow cells and sequencing reagents. At least 54 million 101-base read pairs were generated for each individual library. Data were processed using RTA 1.13.48 and CASAVA 1.8.2. RNA from each sample was sequenced on two separate lanes, obtaining paired-end reads that were 101 bp in length. RNA-seq reads that passed the Illumina platform quality check were used for downstream analyses. RNA-seq reads were aligned to the mouse mm9 reference genome sequence with the STAR (v. 2.3.0e) software using default parameters. RNA-seq reads that mapped to genomic locations for known rRNAs (obtained from the UCSC genome browser) were filtered using split_bam.py included in the RSeQC package (v. 2.3.7). RNA-seq read counts were calculated with the htseq_count (v. 0.5.3p3) software using annotations for protein coding genes obtained from Ensembl (release 67), thus obtaining counts for RNA-seq reads that mapped unambiguously to Ensembl gene models. These RNA-seq counts were used for differential gene expression analysis performed with DESeq2. For the differential gene expression analysis, a comparison of RNA-seq reads counts between two experimental conditions was done, with each condition containing RNA-seq data collected from three biological replicates. The RNA-seq data produced in this study are available at NCBI GEO under accession GSE102271.
To make the heatmap, a regularized log transformation was applied (rlog) to the DESeq2 results data frame (DEseq2). These values for the genes of interest were loaded into the heatmap R package and scaled and clustered by row to generate the heatmap.
Cell culture and siRNA transfection
Primary melanoblasts obtained from FACS were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (not heat inactivated, Gemcell), 200 nM 12-O-tetradecanoylphorbol 13-acetate (TPA, Sigma-Aldrich), 10 ng/mL stem cell factor (Gibco), 0.6 ng/mL basic fibroblast growth factor (Stemgent), 2 mM glutamine, 100 U/mL penicillin, and 100 ug/mL streptomycin. Cells from the immortalized, mouse melanocyte cell line, melan-a (melanInk4a-Arf-1 [85] ) were grown in RPMI 1640 medium supplemented with 10% fetal bovine serum (Gibco), 200 nM TPA (Sigma-Aldrich), 200 pM cholera toxin (Sigma-Aldrich), 2 mM glutamine, 100 U/mL penicillin, and 100 ug/mL streptomycin. Primary and immortalized cells were incubated at 37˚C in humidified air with 10% CO 2 .
siRNA-mediated gene knockdown was performed over 48 hours using Lipofectamine RNAiMAX (Invitrogen) and the following duplex siRNAs (IDT and IDT TriFECTa): siMitf-
; siMitf-OM (same sequence as siMITF with 3, 2 0 -O-methyl-modified uridines along each siRNA); siIrf4_a
and siNC1 (negative control #1, Thermofisher).
ChIP assay
ChIP assay was performed on chromatin lysates extracted from melan-a cells. Two million cells were cross-linked at room temperature for 10 minutes using 1% formaldehyde (final concentration), and chromatin lysates were prepared according to a previously described protocol [86] . The ChIP reaction was carried out by incubating chromatin lysates with anti-MITF antibody (HPA003259; Sigma-Aldrich, Inc., St. Louis, MO). IgG ChIP was performed with a nonspecific antibody control. DNA coprecipitating with anti-MITF and anti-IgG antibodies was recovered on magnetic beads (Dynabeads, Invitrogen), de-cross-linked, and purified using the phenol:chloroform:isoamyl alcohol DNA extraction method. DNA obtained from ChIP as well as input (lysates with no antibody added) was quantified by RT-PCR using primer sets for promoter regions of Stat1, Ifit3, Ifih1, Dct, and a negative control region. DNA sequences for the primer sets used in the experiment are as follows: Stat1 (Forward, GACCAAGTGTCCGGGA CTAA; Reverse, TGCTTTCTTCCAAGTGTCACAG); Ifit3 (Forward, CAGTGATGCACAT GTTACCAA; Reverse, CCAGCTTTTAATGACTACGTCCA); Ifih1(Forward, ACAGGGACC TTGCATACTGG; Reverse, GGCCTGCCTAATGACAGATG); Dct (Forward, CCTGACACA AAGCCAGACAC; Reverse, GAAGCCATCATTAAGGGGATT); negative control region (Catalog#: 71018; Active Motif). Quantitative RT-PCR reaction was performed using the SYBR Green dye protocol (Invitrogen) and data were analyzed using the relative C t method (2 (−ΔCт) ), as described in the Applied Biosystems user manual. ChIP enrichment signals are presented as percent input (input normalization). All ChIP data are from two independent biological replicate experiments.
Poly(I:C) administration
Poly(I:C) (high molecular weight, InvivoGen) for in vitro transfection was first complexed with Lipofectamine 2000 (375 ng poly(I:C)/uL lipofectamine reagent). This complex was added to cell culture growth medium to achieve a final concentration of 250 ng/mL poly(I:C). Primary melanoblasts transfected with this complex were harvested after 9 hours.
Animals treated with poly(I:C) first had a small region of hair removed from their lower back via hand plucking. Four days after plucking, animals were administered an intraperitoneal injection of 100 uL of physiological water with or without 100 μg of poly(I:C). Skin for immunolabeling was harvested from the plucked region of these animals on 7 days post plucking, and animals for live imaging were photographed at approximately 21 days post plucking.
Histological staining and immunofluorescence
Skin isolated from the lower back of plucked mice was immersed in 2% formaldehyde for 30 minutes on ice. Skins were cryoprotected in 10% sucrose overnight, embedded in NEG-50 (Thermo Scientific), frozen, and sectioned with a cryostat (8-10 μm).
For identifying mast cells, skin sections were stained for 2 minutes in toluidine blue solution (18.7 mM toluidine blue, 166 mM urea, 30% ethanol), washed in water, dehydrated in 50% ethanol, and then mounted with Permount. For immunofluorescence, sections were washed in PBS with 0.1% Tween 20, optionally blocked in 1% BSA, and incubated in primary antibody overnight at 4˚C. After washing, the sections were incubated in the appropriate secondary antibody (1:2,000; AlexaFluor, Invitrogen) for 2 hours at room temperature.
Immune cells were detected using primary antibodies against CD3ε (1:50, KT3, Thermofisher), CD4 (1:200, GK1.5, Thermofisher), CD8 (1:200, 53-6.7, Thermofisher), and CD11b (1:1,000, M1/70, Abcam). Quantitation of immune cells was performed by taking five images along a length of skin at 7 dpp (about 5.25 mm total imaged length, see representative images in S2 Fig) and counting the number of positive cells within the epidermis, dermis, and subcutis (about 15 mm 2 total area).
Melanocytes and McSCs were detected using a primary antibody against DCT (1:300; TRP2, Santa Cruz Bio). McSCs and melanocytes were defined as those DCT+ cells residing in the hair bulge (near the border between the dermis and the subcutis) and the hair bulb (surrounding the hair matrix), respectively. Quantitation of DCT+ cells per hair was performed on every fourth section of sequentially obtained skin sections. Apoptotic cells were identified using a primary antibody against CC3 (1:100, Cell Signaling).
Bright-field and fluorescence microscopy and imaging were performed either on an Observer.D1 microscope with an Axiocam Hrc camera (Zeiss) or on an EVOS FL Cell Imaging System (Thermofisher). Images were post processed using Adobe Photoshop. ; rtTA/rtTA mice isolated at P32. These mice were housed in the animal facility independent from those where the remainder of this study was performed. Each point on the graph represents the expression value from skin of an individual animal. The horizontal bars represent the mean, and the asterisks indicate gene expression changes with a q-value of <0.05 using the two-stage linear step-up procedure of Benjamini, Krieger and Yekutieli, with Q = 5%. ISG, interferon stimulated gene; Mitf, melanogenesis associated transcription factor; P, postnatal day; qRT-PCR, quantitative reverse transcriptase polymerase chain reaction; rtTA, reverse tetracycline-controlled transactivator. 
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